Advertisement

Picture [iito] No Tracking 650x80px
Document › Details

Oncopeptides AB. (6/28/19). "Press Release: Oncopeptides Has Completed a Directed Share Issue of approximately SEK 727 Million (USD 78 M) [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]".

Organisations Organisation Oncopeptides AB (Nasdaq Stockholm: ONCO)
  Group Oncopeptides (Group)
  Organisation 2 Carnegie Investment Bank AB
Products Product Melflufen
  Product 2 investment banking
Index term Index term Oncopeptides–SEVERAL: investment, 201906 directed share issue SEK727m ($78m) of 5.015m new shares at SEK145/share
Persons Person Lindberg, Jakob (Oncopeptides AB 201503 CEO)
  Person 2 Piir, Rein (Oncopeptides 201912 Head of Investor Relations)
     


   
Record changed: 2019-12-02

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Oncopeptides (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top